Loetitia Jabri considers the broader implications as healthcare providers embraces new digital connectivity options as part of the Medicine 2.0 era.
Loetitia Jabri
Advertisement
Loetitia Jabri is regulatory, pharmaceutical & medical devices platforms associate director at ProductLife Group.
Articles by Loetitia Jabri
Advertisement
Latest Updated Articles
The Implications of Connected Medical Devices & Digital HealthcareFebruary 21st 2019
Advertisement
Advertisement
Trending on PharmExec
1
Pfizer Receives Unsolicited Mini-Tender Offer for 1 Million Shares from Tutanota: Report
2
Bayer Shares Briefly Dip After Activist Investor Offloads Millions of Dollars in Company Stock
3
Gilead Sciences Enters $2.1 Billion Definitive Agreement to Acquire Ouro Medicines
4
Why CMS Is Tightening ASP Reporting and What Manufacturers Must Get Right
5